Trial name or title	Trial 10769 F1D-US-HGMN
Methods	Allocation: random, no further details. Blindness: double, no further details. Duration: 12 weeks. Design: parallel. Location: not reported. Setting: not reported.
Participants	Diagnosis: schizophrenia or schizoaffective disorder or schizophreniform disorder. N=not reported. Sex: not reportednM, not reported F. Age: 18-65 years. History: duration ill not reported, age at onset not reported
Interventions	1. Olanzapine: Fixed/flexible dose: not reported. Allowed dose range: not reported. Mean dose: not reported. N=not reported. 2. Risperidone: Fixed/flexible dose: not reported. Allowed dose range: not reported. Mean dose: not reported. N=not reported.
Outcomes	Response. Remission. Psychiatric hospitalisations. General Mental State (PANSS). Safety.
Starting date	June 2006
Contact information	not reported.
Notes